CRBN logo

Corbion N.V. Stock Price

ENXTAM:CRBN Community·€963.9m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 26 Fair Values set on narratives written by author

CRBN Share Price Performance

€16.61
-7.91 (-32.26%)
47.9% undervalued intrinsic discount
€31.90
Fair Value
€16.61
-7.91 (-32.26%)
47.9% undervalued intrinsic discount
€31.90
Fair Value
Price €16.61
AnalystHighTarget €31.90
AnalystConsensusTarget €22.84
AnalystLowTarget €14.00

CRBN Community Narratives

AnalystHighTarget·Updated
Fair Value €31.9 47.9% undervalued intrinsic discount

Global Sustainable Demand And PLA Breakthroughs Will Transform Markets

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AnalystConsensusTarget·Updated
Fair Value €22.73 26.9% undervalued intrinsic discount

Thai Ramp-Up And Chinese Approvals Will Boost Efficiency

0users have liked this narrative
0users have commented on this narrative
15users have followed this narrative
AnalystLowTarget·Updated
Fair Value €14 18.6% overvalued intrinsic discount

Rising Regulatory And Feedstock Costs Will Erode Future Margins

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative

Recent CRBN News & Updates

Corbion N.V.'s (AMS:CRBN) Intrinsic Value Is Potentially 65% Above Its Share Price

Jun 23
Corbion N.V.'s (AMS:CRBN) Intrinsic Value Is Potentially 65% Above Its Share Price

Here's Why Shareholders Should Examine Corbion N.V.'s (AMS:CRBN) CEO Compensation Package More Closely

May 07
Here's Why Shareholders Should Examine Corbion N.V.'s (AMS:CRBN) CEO Compensation Package More Closely

At €17.39, Is Corbion N.V. (AMS:CRBN) Worth Looking At Closely?

Apr 10
At €17.39, Is Corbion N.V. (AMS:CRBN) Worth Looking At Closely?

Corbion's (AMS:CRBN) Earnings May Just Be The Starting Point

Mar 26
Corbion's (AMS:CRBN) Earnings May Just Be The Starting Point
User avatar

Expanding Into Natural Antioxidants And Efficiency Improvements Will Drive Future Success

Strategic initiatives and operational optimizations are expected to significantly enhance EBITDA margins and net margins.

Here's What To Make Of Corbion's (AMS:CRBN) Decelerating Rates Of Return

Feb 28
Here's What To Make Of Corbion's (AMS:CRBN) Decelerating Rates Of Return

Corbion N.V. Key Details

€1.3b

Revenue

€958.2m

Cost of Revenue

€338.4m

Gross Profit

€272.8m

Other Expenses

€65.6m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
1.13
Gross Margin
26.10%
Net Profit Margin
5.06%
Debt/Equity Ratio
61.3%

Corbion N.V. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Excellent balance sheet, good value and pays a dividend.

2 Risks
3 Rewards

About CRBN

Founded
1919
Employees
2403
CEO
Olivier Rigaud
WebsiteView website
www.corbion.com

Corbion N.V. provides lactic acid and lactic acid derivatives, food preservation solutions, functional blends, and algae ingredients in the Netherlands, the United States, Asia, rest of North Americas, the rest of Europe, the Middle East, and Africa. It operates through Functional Ingredients & Solutions, and Health & Nutrition segments. The company offers acidification, color retention, decontamination, food safety and preservation, freshness and shelf life, health and nutrition, strengthening conditioning, and taste and texture food solutions; Purasorb R&D, a solution that offers a range of custom synthesis options; biochemical specialties solutions, such as solvency, antimicrobial, moisturization, and pharma; and algae ingredients solutions, including replacing fish oil and sustainable omega-3 sourcing. It also provides food antioxidants, fermentation and preservation ingredients, flavors, fortification, and lactic acid lactates and derivatives; chemical products, such as agrochemicals, safe solvents, polymer additives, and functional ingredients for other chemical industries; bioplastic products; pharma products; and personal care products, including skin acre, hair care, rinse-off, moisturization, skin lightening, anti-aging and personal care solutions, oral health, natural pH adjustment, emulsifiers and surfactants, and antimicrobial. In addition, the company offers Puralact B3, a resin formulator for coatings and adhesives; Purasolv, a solvent for supporting sustainable production of healthier and stronger crops; Purasolv BL, a green solution; and AlgaVia, culinary algae oils. It offers ingredient solutions for the food, home and personal care, animal nutrition, supplements, pharmaceuticals, medical devices, and bioplastics markets. The company markets its products through a network of sales offices and distributors. Corbion N.V. has agreement to collaborate with BRAIN Biotech AG develop novel biobased antimicrobial compounds and its derivatives. The company was formerly known as CSM N.V. and changed its name to Corbion N.V. in October 2013. Corbion N.V. was incorporated in 1919 and is headquartered in Amsterdam, the Netherlands.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Dutch Market Performance

  • 7 Days: 4.4%
  • 3 Months: 11.5%
  • 1 Year: 10.7%
  • Year to Date: 16.4%
The market is up 4.4% over the last week, with the Information Technology sector leading the way, up 8.4%. In the last year, the market has climbed 11%. Looking forward, earnings are forecast to grow by 11% annually. Market details ›